APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.
0/5 보강
APA
Yang F, Long K, et al. (2026). APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.. Genes & diseases, 13(4), 101813. https://doi.org/10.1016/j.gendis.2025.101813
MLA
Yang F, et al.. "APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC.." Genes & diseases, vol. 13, no. 4, 2026, pp. 101813.
PMID
41884711
같은 제1저자의 인용 많은 논문 (5)
- Evaluation of Preoperative and Postoperative Patient Satisfaction and Quality of Life in Patients Undergoing Rhinoplasty: A Systematic Review and Meta-Analysis.
- NK cell infusion is well-tolerated and shows preliminary efficacy in patients with recurrent hepatocellular carcinoma post-liver transplantation : a phase I trial.
- Short-chain acyl-CoA dehydrogenase initiates mtDNA demethylation and leakage to fuel antitumor immunity in colorectal cancer.
- Ultrasound Elastography Radiomics: A Novel Approach for Benign-Malignant Differentiation of BI-RADS Category 4 Breast Masses.
- Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis.